STOCK-BASED COMPENSATION (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2025 |
Dec. 31, 2024 |
| Share-Based Payment Arrangement [Abstract] |
|
|
| Schedule of Stock-Based Compensation Expense |
Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations is classified as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Cost of revenue |
|
$ |
— |
|
|
$ |
119,880 |
|
|
$ |
105,734 |
|
|
$ |
245,512 |
|
Research and development |
|
|
— |
|
|
|
126,864 |
|
|
|
93,425 |
|
|
|
265,914 |
|
Selling and marketing |
|
|
6,381 |
|
|
|
(280,124 |
) |
|
|
202,869 |
|
|
|
(199,199 |
) |
General and administrative |
|
|
291,101 |
|
|
|
483,952 |
|
|
|
392,618 |
|
|
|
752,460 |
|
Total stock-based compensation expense |
|
$ |
297,482 |
|
|
$ |
450,572 |
|
|
$ |
794,646 |
|
|
$ |
1,064,687 |
|
|
Total stock-based compensation expense recognized in the Company’s consolidated statements of operations is classified as follows:
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, |
|
|
|
2024 |
|
|
2023 |
|
Cost of revenue |
|
$ |
466,658 |
|
|
$ |
640,847 |
|
Research and development |
|
|
476,666 |
|
|
|
617,386 |
|
Selling and marketing (1) |
|
|
(181,160 |
) |
|
|
266,675 |
|
General and administrative |
|
|
1,103,931 |
|
|
|
965,501 |
|
Total stock-based compensation expense |
|
$ |
1,866,095 |
|
|
$ |
2,490,409 |
|
_______________ (1)Includes the reversal of stock compensation expense due to the departure of our Chief Marketing and Sales Officer in April 2024 and the resultant forfeiture of his unvested awards.
|
| Schedule of Restricted Stock Units |
The following table shows a summary of the Company's RSUs outstanding as of June 30, 2025 and December 31, 2024 as well as activity the period then ended:
|
|
|
|
|
|
|
|
|
|
|
RSUs |
|
|
|
Number of Shares |
|
|
Weighted Average Grant Date Fair Value |
|
Unvested at December 31, 2024 |
|
|
4,562 |
|
|
$ |
223.07 |
|
RSUs vested |
|
|
(1,869 |
) |
|
$ |
223.21 |
|
RSUs forfeited |
|
|
(275 |
) |
|
$ |
36.42 |
|
Unvested at June 30, 2025 |
|
|
2,418 |
|
|
$ |
244.19 |
|
|
The following table shows a summary of the Company's RSUs outstanding as of December 31, 2024 as well as activity the year then ended:
|
|
|
|
|
|
|
|
|
|
|
RSUs |
|
|
|
Number of Shares |
|
|
Weighted Average Grant Date Fair Value |
|
Unvested at December 31, 2023 |
|
|
22,213 |
|
|
$ |
208.80 |
|
RSUs granted |
|
|
45,725 |
|
|
$ |
5.38 |
|
RSUs vested |
|
|
(52,789 |
) |
|
$ |
24.33 |
|
RSUs forfeited |
|
|
(10,587 |
) |
|
$ |
94.46 |
|
Unvested at December 31, 2024 |
|
|
4,562 |
|
|
$ |
223.07 |
|
The
|
| Summary of Stock Options Activity |
A summary of stock option activity is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Stock Options Outstanding |
|
|
Weighted-Average Exercise Price |
|
|
Weighted-Average Remaining Contractual Life (Years) |
|
|
Aggregate Intrinsic Value |
|
Options outstanding at December 31, 2024 |
|
|
218,430 |
|
|
$ |
40.80 |
|
|
|
7.1 |
|
|
$ |
7,375.15 |
|
Options cancelled or forfeited |
|
|
(82,919 |
) |
|
$ |
23.99 |
|
|
|
|
|
|
|
Options outstanding at June 30, 2025 |
|
|
135,511 |
|
|
$ |
51.08 |
|
|
|
4.6 |
|
|
$ |
— |
|
Options exercisable at June 30, 2025 |
|
|
95,254 |
|
|
$ |
63.62 |
|
|
|
2.9 |
|
|
$ |
— |
|
Options vested and expected to vest at June 30, 2025 |
|
|
135,511 |
|
|
$ |
51.08 |
|
|
|
4.6 |
|
|
$ |
— |
|
|
A summary of stock option activity is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Stock Options Outstanding |
|
|
Weighted-Average Exercise Price |
|
|
Weighted-Average Remaining Contractual Life (Years) |
|
|
Aggregate Intrinsic Value |
|
Options outstanding at December 31, 2023 |
|
|
188,865 |
|
|
$ |
74.41 |
|
|
|
7.9 |
|
|
$ |
— |
|
Options granted |
|
|
64,564 |
|
|
$ |
2.77 |
|
|
|
|
|
|
|
Options exercised |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
|
|
Options cancelled or forfeited |
|
|
(34,999 |
) |
|
$ |
152.01 |
|
|
|
|
|
|
|
Options outstanding at December 31, 2024 |
|
|
218,430 |
|
|
$ |
40.80 |
|
|
|
7.1 |
|
|
$ |
7,375.15 |
|
Options exercisable at December 31, 2024 |
|
|
143,214 |
|
|
$ |
49.70 |
|
|
|
6.1 |
|
|
$ |
7,375.15 |
|
Options vested and expected to vest at December 31, 2024 |
|
|
218,430 |
|
|
$ |
40.80 |
|
|
|
7.0 |
|
|
$ |
7,375.15 |
|
|
| Summary of Assumptions Utilized for Option Grants |
A summary of the weighted-average assumptions the Company utilized for option grants during the six months ended June 30, 2025 and 2024, respectively, are as follows:
|
|
|
|
|
|
|
Six Months Ended June 30, |
|
|
2025 |
|
2024 |
Expected term (in years) |
|
N/A |
|
4.0 |
Expected volatility |
|
N/A |
|
47.8% |
Risk-free interest rate |
|
N/A |
|
4.0% |
Expected dividend yield |
|
N/A |
|
0.0% |
|
A summary of the assumptions the Company utilized for option grants during the years ended December 31, 2024 and 2023, respectively, are as follows:
|
|
|
|
|
|
|
Year ended December 31, |
|
|
2024 |
|
2023 |
Expected term (in years) |
|
4.0 |
|
0.75-5.0 |
Expected volatility |
|
47.8% - 55.0% |
|
44.9%-47.6% |
Risk-free interest rate |
|
4.0% - 4.5% |
|
3.8%-5.5% |
Expected dividend yield |
|
0.0% |
|
0.0% |
|